Search clinical trials for: Comirnaty

Total 64 results

Medical University Innsbruck
Medical University of Graz; Medical University of Vienna

Recruiting

Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2 (HeVacc)

SARS-CoV2 Infection

Austria
Jules Bordet Institute
Roche Pharma AG

Terminated

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 (I-SPARC)

Cancer

Belgium
Radboud University Medical Center

Terminated

Intradermal Administration of a COVID-19 mRNA Vaccine in Elderly (HVaNa)

COVID-19 | Vaccination; Infection

Netherlands
Bavarian Nordic

Completed

ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2

COVID-19 Disease

United States, Denmark, Belgium
Walvax Biotechnology Co., Ltd.
Shanghai RNACure Biopharma Co., Ltd.

Not yet recruiting

A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

COVID-19
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine

COVID-19 | Sars-CoV-2 Infection
Sinocelltech Ltd.

Withdrawn

A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine

COVID-19 | SARS-CoV2 Infection
Pfizer

Completed

Special Investigation of COMIRNATY in the Population With Underlying Diseases

COVID-19

Japan
Pfizer

Active, not recruiting

Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

COVID-19 | SARS-CoV-2

Japan
BioNTech SE

Completed

A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects

COVID-19 | SARS-CoV-2 Infection

Germany
Walvax Biotechnology Co., Ltd.
Shanghai RNACure Biopharma Co., Ltd.

Not yet recruiting

A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

COVID-19
The University of Hong Kong

Active, not recruiting

Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study)

COVID 19 Vaccine

Hong Kong
Pfizer

Completed

Drug Use Investigation of COMIRNATY Intramuscular Injection

COVID-19

Japan
Rajavithi Hospital
Department of Medical services

Withdrawn

IntraDermal Versus Intramuscular Comirnaty® Efficacy Study (PRIDE)

Covid19 | Covid19 Vaccine
KK Women's and Children's Hospital
Duke-NUS Graduate Medical School

Recruiting

Determining Reactogenicity and Immunogenicity of Delayed COVID-19 Vaccine Schedule in Children

COVID-19 | Vaccine Reaction | Children, Only

Singapore
Assistance Publique - Hôpitaux de Paris

Recruiting

Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings (PACIFIC)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia

France
Pfizer

Completed

This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.

COVID-19 | Influenza, Human

United States
GreenLight Biosciences, Inc.

Withdrawn

A Phase I/II Study of GLB-COV2-043 as a COVID-19 Vaccine Booster

COVID-19
Shanghai Zerun Biotechnology Co.,Ltd

Active, not recruiting

Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.

COVID-19 | SARS-CoV-2 Infection

Mali
Everest Medicines (Singapore) Pte. Ltd.

Not yet recruiting

Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older

SARS-CoV-2 Infection
Hipra Scientific, S.L.U

Active, not recruiting

Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine

SARS-CoV2 Infection

Spain
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Active, not recruiting

A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine

COVID-19 | SARS-CoV-2 Infection
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine (CoVFlu)

COVID-19 | Influenza

Italy
Oliver Cornely, MD
European Commission; VACCELERATE

Completed

Assessing Immune Response of Different COVID-19 Vaccines in Older Adults (EU-COVAT-1)

COVID-19 | Vaccination; Infection | Vaccination Reaction

Spain, Ireland, Germany, Norway, Lithuania
Federal University of Espirito Santo
Centro de Pesquisas René Rachou; Secretaria de Estado da Saúde do Espírito...

Not yet recruiting

Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly (Plus_Booster)

COVID-19 | Vaccine Adverse Reaction | Vaccine-Preventable Diseases

Brazil
Universitätsklinikum Hamburg-Eppendorf
Ludwig-Maximilians - University of Munich; Philipps University Marburg Medical... and other collaborators

Completed

Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19

Covid19

Germany
Cellid Co., Ltd.

Not yet recruiting

Immunogenicity and Safety of AdCLD-CoV19-1 OMI as a Booster: A COVID-19 Preventive Vaccine in Healthy Volunteers (COVID-19)

COVID-19 | Vaccines

Korea, Republic of
The University of Hong Kong

Active, not recruiting

Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study)

COVID-19 Vaccination

Hong Kong
Instituto de Investigación Hospital Universitario...
Instituto de Salud Carlos III; Spanish Clinical Research Network - SCReN

Active, not recruiting

Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose (CombiVacS)

Covid19

Spain
Azidus Brasil
SENAI CIMATEC

Not yet recruiting

Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine

COVID-19 | COVID-19 Vaccine
Assistance Publique - Hôpitaux de Paris
IREIVAC/COVIREIVAC Network

Active, not recruiting

Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adults (COVIBOOSTAnci1)

COVID-19 Vaccines

France
Murdoch Childrens Research Institute

Completed

Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction (COSI BAIR)

COVID-19 | Vaccine Reaction | Immunization; Infection

Australia
Clover Biopharmaceuticals AUS Pty Ltd

Completed

Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults

COVID-19

Philippines
UMC Utrecht
Sanquin Research & Blood Bank Divisions; National Institute for Public Health... and other collaborators

Recruiting

Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome. (PRIDE)

Down Syndrome | SARS-CoV-2 Vaccination

Netherlands
Karolinska University Hospital
Karolinska Institutet

Active, not recruiting

COVID-19 Vaccination of Immunodeficient Persons (COVAXID) (COVAXID)

Covid19

Sweden
Hipra Scientific, S.L.U

Completed

Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain
ANRS, Emerging Infectious Diseases
LinKinVax; Vaccine Research Institute (VRI), France

Not yet recruiting

Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.

COVID-19
University of Melbourne
London School of Hygiene and Tropical Medicine; The Alfred; University of Adelaide and other collaborators

Recruiting

Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection

Influenza, Human | SARS-CoV-2 Infection

Australia
Murdoch Childrens Research Institute
Coalition for Epidemic Preparedness Innovations; The Peter Doherty Institute...

Active, not recruiting

Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.

COVID-19

Mongolia
Italian Group for the study of Inflammatory Bowel...

Unknown

Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD) (ESCAPE-IBD)

Inflammatory Bowel Diseases
Murdoch Childrens Research Institute
Coalition for Epidemic Preparedness Innovations; The Peter Doherty Institute...

Completed

Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV). (MIACoV)

COVID-19

Australia
Hipra Scientific, S.L.U
National Institute of Hygiene and Epidemiology, Vietnam; Laboratorios Hipra...

Completed

Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Vietnam
Hipra Scientific, S.L.U
Laboratorios Hipra, S.A.

Completed

Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain
University of Michigan
The Wallace Foundation

Recruiting

Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction

COVID-19 | Corona Virus Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose

Systemic Allergic Reaction

United States
University Medicine Greifswald

Active, not recruiting

Adaptive Immune Response to COVID-19 Vaccination (AICOVI)

SARS-CoV-2 Vaccination

Germany
University of Liege
Pfizer

Recruiting

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Coronavirus Disease 2019 (Covid19) | Hematopoietic Neoplasms

Belgium

3

Subscribe